Peregrine Asset Advisers’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $342K | Hold |
4,900
| – | – | 0.11% | 128 |
|
|
2025
Q1 | $360K | Hold |
4,900
| – | – | 0.13% | 115 |
|
|
2024
Q4 | $321K | Sell |
4,900
-31
| -0.6% | -$2.03K | 0.12% | 118 |
|
|
2024
Q3 | $384K | Hold |
4,931
| – | – | 0.13% | 121 |
|
|
2024
Q2 | $385K | Hold |
4,931
| – | – | 0.15% | 109 |
|
|
2024
Q1 | $334K | Hold |
4,931
| – | – | 0.13% | 118 |
|
|
2023
Q4 | $332K | Hold |
4,931
| – | – | 0.16% | 111 |
|
|
2023
Q3 | $334K | Buy |
+4,931
| New | +$334K | 0.17% | 106 |
|
|
2022
Q2 | – | Sell |
-3,200
| Closed | -$212K | – | 81 |
|
|
2022
Q1 | $212K | Buy |
+3,200
| New | +$212K | 0.11% | 104 |
|
|
2020
Q2 | – | Sell |
-3,200
| Closed | -$143K | – | 98 |
|
|
2020
Q1 | $143K | Buy |
+3,200
| New | +$143K | 0.11% | 97 |
|